VTVT (STOCKS)
vTv Therapeutics Inc. Class A Common Stock
$33.540000
+0.775000 (+2.37%)
Prev close: $32.765000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Paul Jai Sekhri
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $132.79M
- Employees
- 23
- P/E (TTM)
- -35.47
- P/B (TTM)
- 1.43
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$1.94 | $-0.10 | +2.0369 | +2,102.06% |
|
Dec 2025 (Q4)
|
$-0.58 | $-1.11 | +0.5298 | +47.74% |
|
Sep 2025 (Q3)
|
$-1.08 | $-1.00 | -0.0804 | -8.04% |
|
Jun 2025 (Q2)
|
$-0.92 | $-0.84 | -0.0785 | -9.33% |
Financial Statements
| Revenues | $36.84M |
| Operating Expenses | $39.88M |
| Research and Development | $24.01M |
| Other Operating Expenses | $15.87M |
| Operating Income/Loss | -$3.04M |
| Income/Loss From Continuing Operations After Tax | -$729.00K |
| Income/Loss From Continuing Operations Before Tax | -$729.00K |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$729.00K |
| Net Income/Loss Attributable To Noncontrolling Interest | -$2.98M |
| Net Income/Loss Attributable To Parent | $2.25M |
| Net Income/Loss Available To Common Stockholders, Basic | $2.25M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Assets | $98.81M |
| Current Assets | $98.81M |
| Prepaid Expenses | $521.00K |
| Other Current Assets | $98.29M |
| Noncurrent Assets | $5.00K |
| Liabilities | $8.85M |
| Current Liabilities | $6.88M |
| Noncurrent Liabilities | $1.97M |
| Equity | $89.96M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $89.96M |
| Liabilities And Equity | $98.81M |
| Net Cash Flow From Operating Activities | -$10.41M |
| Net Cash Flow From Operating Activities, Continuing | -$10.41M |
| Net Cash Flow | $14.84M |
| Net Cash Flow, Continuing | $14.84M |
| Comprehensive Income/Loss | -$729.00K |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$729.00K |
| Other Comprehensive Income/Loss | $0.00 |